David A. Siegel Karyopharm Therapeutics Inc. Call Options Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding KPTI
# of Institutions
94Shares Held
59.6MCall Options Held
547KPut Options Held
67K-
Vanguard Group Inc Valley Forge, PA7.65MShares$4.82 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.32MShares$3.98 Million0.01% of portfolio
-
Palo Alto Investors LP Palo Alto, CA4.91MShares$3.09 Million0.53% of portfolio
-
Black Rock Inc. New York, NY4.17MShares$2.63 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.51MShares$2.21 Million0.0% of portfolio
About Karyopharm Therapeutics Inc.
- Ticker KPTI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 79,806,600
- Market Cap $50.3M
- Description
- Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...